1. Home
  2. BLUE vs NTIP Comparison

BLUE vs NTIP Comparison

Compare BLUE & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLUE
  • NTIP
  • Stock Information
  • Founded
  • BLUE 1992
  • NTIP 1990
  • Country
  • BLUE United States
  • NTIP United States
  • Employees
  • BLUE N/A
  • NTIP N/A
  • Industry
  • BLUE Biotechnology: Biological Products (No Diagnostic Substances)
  • NTIP Multi-Sector Companies
  • Sector
  • BLUE Health Care
  • NTIP Miscellaneous
  • Exchange
  • BLUE Nasdaq
  • NTIP Nasdaq
  • Market Cap
  • BLUE 36.9M
  • NTIP 31.9M
  • IPO Year
  • BLUE 2013
  • NTIP 1998
  • Fundamental
  • Price
  • BLUE $4.09
  • NTIP $1.22
  • Analyst Decision
  • BLUE Hold
  • NTIP
  • Analyst Count
  • BLUE 7
  • NTIP 0
  • Target Price
  • BLUE $44.60
  • NTIP N/A
  • AVG Volume (30 Days)
  • BLUE 524.5K
  • NTIP 16.8K
  • Earning Date
  • BLUE 05-08-2025
  • NTIP 05-09-2025
  • Dividend Yield
  • BLUE N/A
  • NTIP 7.97%
  • EPS Growth
  • BLUE N/A
  • NTIP N/A
  • EPS
  • BLUE N/A
  • NTIP N/A
  • Revenue
  • BLUE $83,807,000.00
  • NTIP $100,000.00
  • Revenue This Year
  • BLUE $218.58
  • NTIP N/A
  • Revenue Next Year
  • BLUE N/A
  • NTIP N/A
  • P/E Ratio
  • BLUE N/A
  • NTIP N/A
  • Revenue Growth
  • BLUE 184.12
  • NTIP N/A
  • 52 Week Low
  • BLUE $3.56
  • NTIP $1.17
  • 52 Week High
  • BLUE $28.60
  • NTIP $2.02
  • Technical
  • Relative Strength Index (RSI)
  • BLUE 43.15
  • NTIP 41.49
  • Support Level
  • BLUE $3.83
  • NTIP $1.19
  • Resistance Level
  • BLUE $5.15
  • NTIP $1.28
  • Average True Range (ATR)
  • BLUE 0.40
  • NTIP 0.05
  • MACD
  • BLUE -0.05
  • NTIP -0.00
  • Stochastic Oscillator
  • BLUE 18.44
  • NTIP 35.71

About BLUE bluebird bio Inc.

bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.

About NTIP Network-1 Technologies Inc.

Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property assets. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.

Share on Social Networks: